
Cytaright 100mg/1ml Injection
Salt Composition: Cytarabine
Expiry Date: 01/2028
Inclusive of all taxes
1 Injection

Cytaright 100mg/1ml Injection
1 Injection
Cytarabine
Salt Composition
Cytarabine
Storage
Below 25°C
Expiry Date
01/2028
Marketer
metta lifescinse
Brand
cytaright

Biobin 100mg/1ml Injection
1 Injection
Cytarabine
Salt Composition
Cytarabine
Storage
Below 25°C
Expiry Date
01/2028
Marketer
zydus
Brand
biobin
5966.png&w=1920&q=75)
MAGIC DEALS
Enquire
Apply Promo Code
Available CouponsCytaright 100mg/1ml Injection
Inclusive of all taxes
In Stock
Authorized
Global Reach
Verified Logistics
The price displayed is inclusive of applicable taxes. Any additional fee (such as shipping fee, handling and/or platform fee etc.) will be clearly disclosed before you complete your purchase.
About The Product
leukemia Cancer
Cytaright 100mg/1ml Injection is a chemotherapy based anticancer drug. It contains Cytarabine as an active ingredient that belongs to the antimetabolite class of drug. It is used to treat certain types of leukaemias (a type of blood cancer with too many white blood cells), including acute myeloid leukaemia (AML) and chronic myelogenous leukaemia (CML). It also treats and prevents meningeal leukaemia as determined by the doctor. It can be prescribed alone or with other chemotherapy medications.
Cytaright 100mg/1ml Injection Uses and Indications
Acute myeloid leukemia (AML)
Chronic myelogenous leukemia (CML)
Meningeal leukaemia
Cytaright 100mg/1ml Injection Side Effects
The human body shows undesired symptoms after taking Cytaright 100mg/1ml Injection. Usually, they disappear with time as the body adjusts to the medicine. These side effects don't need special medical attention. It is advised to consult your doctor if these symptoms become unmanageable.
Common side effects include:
Rash
Skin ulcer
Nausea
Vomiting
Hair loss
Abdominal pain
Anal ulcers
Anemia (low number of red blood cells)
Decreased white blood cell count
Fever
Infection
Abnormal liver function
Low blood platelets
Mouth ulcer
Pneumonia
Sepsis
Mouth sore
Stomatitis (Inflammation of the mouth)
Cytaright 100mg/1ml Injection Dosage and How To Take It
Cytaright 100mg/1ml is available in injection form and is advised to be taken as per the doctor's prescription. It can be given under the skin (subcutaneous) into a vein (intravenously) into a muscle (intramuscularly) or the spine (intrathecal) by a doctor or nurse under strict medical supervision.Taking this injection in the wrong way may give you severe side effects.
In case of overdose, contact your healthcare provider or doctor and they will provide you with medical attention. Missing or overdosing will impact the overall health of the patients and may also have side effects. So, it is always advisable to follow the prescription of the doctor strictly.
How Cytaright 100mg/1ml Injection Works
Cytaright 100mg/1ml Injection is a cytotoxic drug that contains Cytarabine as an active ingredient. It works by primarily killing cancer cells by interfering with their DNA synthesis.
It causes the DNA strands to cross-link, that stops the cells from dividing and ultimately leads to their death. Results in slowing or stopping the growth of cancer cells in your body.
Safety Advice for Cytaright 100mg/1ml Injection
Do not take Cytaright 100mg/1ml Injection without consulting the doctor in case of pregnancy, as it can be unsafe to take it during this period.
Cytaright 100mg/1ml Injection may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving.
Cytaright 100mg/1ml Injection is safe for use in kidney disease if prescribed by the doctor. No dosage adjustment is necessary for this injection.
Share your medical history with the doctor before starting the Cytaright 100mg/1ml Injection. Do not take it without consulting a doctor if you have any liver related issue.
FAQs About Cytaright 100mg/1ml Injection
Cytaright 100mg/1ml can be given under the skin (subcutaneous) into a vein (intravenously) into a muscle (intramuscularly) or the spine (intrathecal) by a doctor or nurse under strict medical supervision.
References
Chhikara, B. S., & Parang, K. (2010). Development of cytarabine prodrugs and delivery systems for leukemia treatment. Expert opinion on drug delivery , 7 (12), 1399-1414.
Magina, K. N., Pregartner, G., Zebisch, A., Wölfler, A., Neumeister, P., Greinix, H. T., ... & Sill, H. (2017). Cytarabine dose in the consolidation treatment of AML: a systematic review and meta-analysis. Blood, the Journal of the American Society of Hematology , 130 (7), 946-948.
Löwenberg, B., Pabst, T., Vellenga, E., van Putten, W., Schouten, H. C., Graux, C., ... & Ossenkoppele, G. J. (2011). Cytarabine dose for acute myeloid leukemia. New England Journal of Medicine , 364 (11), 1027-1036.
Hamada, A., Kawaguchi, T., & Nakano, M. (2002). Clinical pharmacokinetics of cytarabine formulations. Clinical pharmacokinetics , 41 (10), 705-718.
El-Subbagh, H. I., & Al-Badr, A. A. (2009). Cytarabine. In profiles of drug substances, excipients and related methodology (Vol. 34, pp. 37-113). Academic Press.
Löwenberg, B., Pabst, T., Vellenga, E., van Putten, W., Schouten, H. C., Graux, C., ... & Ossenkoppele, G. J. (2011). Cytarabine dose for acute myeloid leukemia. New England Journal of Medicine , 364 (11), 1027-1036.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
.jpeg%3FupdatedAt%3D1763121181831&w=128&q=75)